Evidence map›Paper›PMID 42147645›Full record

ArticleCureus2026

Ischemic Type of Central Vein Occlusion in a Patient With Bietti Crystalline Dystrophy: A Longitudinal Follow-Up of 12 Years.

Hamit Ali, Mehmet Kocabey, Ziya Ayhan, Ahmet Okay Caglayan, Ali Osman Saatci

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hamit AliDepartment of Ophthalmology, Dokuz Eylül University, Izmir, TUR.
Mehmet KocabeyDepartment of Medical Genetics, Dokuz Eylül University, Izmir, TUR.
Ziya AyhanDepartment of Ophthalmology, Dokuz Eylül University, Izmir, TUR.
Ahmet Okay CaglayanDepartment of Medical Genetics, Dokuz Eylül University, Izmir, TUR.
Ali Osman SaatciDepartment of Ophthalmology, Dokuz Eylül University, Izmir, TUR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bietti crystalline dystrophy (BCD) is a rare chorioretinal dystrophy associated with mutations in the CYP4V2 gene, characterized by intraretinal crystalline deposits and progressive chorioretinal degeneration. Retinal vein occlusion (RVO) is exceedingly rare in BCD, with only one previously reported case of tributary RVO without a detailed clinical description. We hereby describe a 44-year-old man with genetically proven stage 2 BCD who developed right central RVO (CRVO) eight years following the initial diagnosis in 2013. Though he did not notice any new visual disturbance in the right eye, routine fundus examination revealed subtle peripheral microvascular abnormalities and intraretinal small hemorrhages 360 degrees in 2021, and fluorescein angiography demonstrated nearly 360-degree peripheric nonperfusion with scattered microaneurysms, consistent with the diagnosis of ischemic CRVO. Four years later, the patient developed peripheric retinal neovascularizations and a small preretinal hemorrhage in his right eye that was managed solely with scatter laser photocoagulation. Unlike a previously reported case with retinitis pigmentosa and CRVO, in which neovascular complications did not arise, most likely due to extensive peripheral chorioretinal atrophy related to low VEGF levels, our case exhibited less peripheral chorioretinal atrophy; therefore, peripheral ischemia led to the development of retinal neovascularizations. Patients with BCD may not perceive peripheral retinal alterations due to their already compromised central vision; therefore, regular clinical visits seem beneficial to detect potential fundus changes promptly, as demonstrated in the present case.

Indexed as

bietti crystalline dystrophyretinal neovascularizationretinal vein occlusionretinitis pigmentosarvo

Identifiers

PMID42147645
PMCPMC13178709

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.